ARTICLE | Company News
Array BioPharma cancer news
June 20, 2011 7:00 AM UTC
The restructuring is expected to save about $20 million in its fiscal year ending June 30, 2012. At March 31, Array had $75.8 million in cash and a nine-month operating loss of $24.6 million. ...